Alternative Data for LeMaitre Vascular
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 28 | Sign up | Sign up | Sign up |
| Sentiment | 83 | Sign up | Sign up | Sign up |
| Webpage traffic | 11,000 | Sign up | Sign up | Sign up |
| Employee Rating | 66 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 521 | Sign up | Sign up | Sign up |
| X Followers | 407 | Sign up | Sign up | Sign up |
| X Mentions | 83 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 420 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| ESG | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 46 | Sign up | Sign up | Sign up |
About LeMaitre Vascular
LeMaitre Vascular Inc provides medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons.
| Price | $108.06 |
| Target Price | Sign up |
| Volume | 262,628 |
| Market Cap | $2.46B |
| Year Range | $79.42 - $113.69 |
| Dividend Yield | 0.75% |
| PE Ratio | 42.88 |
| Analyst Rating | 100% buy |
| Industry | Medical & Dental Instruments |
In the news
LeMaitre Vascular, Inc. (LMAT): A Bull Case TheoryFebruary 28 - Yahoo Entertainment |
|
Barrington Research Maintains Outperform on LeMaitre Vascular, Maintains $95 Price TargetFebruary 19 - Benzinga |
|
 |
Dividend Champion, Contender, And Challenger Highlights: Week Of March 8March 6 - SeekingAlpha |
2 Profitable Stocks with Exciting Potential and 1 We Turn DownMarch 4 - Yahoo |
|
 |
Global Peripheral Vascular Devices Market Poised for Robust Growth at a CAGR of ~6% Through 2032 as Demand for Minimally Invasive Treatments Surges | DelveInsightMarch 3 - PR Newswire UK |
Dividend Champion, Contender, And Challenger Highlights: Week Of March 1February 27 - SeekingAlpha |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 61M | 15M | 46M | 17M | 26M | 0.620 |
| Q2 '25 | 64M | 19M | 45M | 14M | 22M | 0.600 |
| Q1 '25 | 60M | 18M | 41M | 11M | 18M | 0.480 |
| Q4 '24 | 56M | 17M | 39M | 11M | 20M | 0.490 |
| Q3 '24 | 55M | 18M | 37M | 11M | 16M | 0.490 |
Insider Transactions View All
| Roberts David B filed to sell 14,667 shares at $107.7. March 13 '26 |
| Kamke Trent G filed to sell 6,677 shares at $108.5. March 13 '26 |
| LeMaitre George W filed to sell 1,476,500 shares at $107.8. March 2 '26 |
| Roberts David B filed to sell 17,979 shares at $106.8. March 2 '26 |
| Kamke Trent G filed to sell 6,677 shares at $110.3. March 2 '26 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Align TechnologyALGN |
$164.23 1.6% | 52 |
 |
DentsplyXRAY |
$11.54 2.2% | 54 |
 |
iRhythm TechnologiesIRTC |
$113 1.5% | 43 |
 |
NovoCureNVCR |
$12.06 0.4% | 41 |
 |
DanaherDHR |
$187.32 0.6% | 60 |
Read more about LeMaitre Vascular (LMAT) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews & business outlook.
FAQ - LeMaitre Vascular
The Market Cap of LeMaitre Vascular is $2.46B.
As of today, LeMaitre Vascular's PE (Price to Earnings) ratio is 42.88.
Currently, the price of one share of LeMaitre Vascular stock is $108.06.
The LMAT stock price chart above provides a comprehensive visual representation of LeMaitre Vascular's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling LeMaitre Vascular shares. Our platform offers an up-to-date LMAT stock price chart, along with technical data analysis and alternative data insights.
Yes, LeMaitre Vascular (LMAT) offers dividends to its shareholders, with a dividend yield of 0.75%. This dividend yield represents LeMaitre Vascular's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering LeMaitre Vascular in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
Some of the similar stocks of LeMaitre Vascular are Align Technology, Dentsply, iRhythm Technologies, NovoCure, and Danaher.
